|
Acquisitions (Fair Values Of The Assets Acquired And Liabilities Assumed) (Details) (USD $)
In Thousands, unless otherwise specified |
Dec. 31, 2011
Arresto Biosciences, Inc. [Member]
|
Jan. 14, 2011
Arresto Biosciences, Inc. [Member]
|
Jan. 14, 2011
Arresto Biosciences, Inc. [Member]
Deferred Tax Assets [Member]
|
Jan. 14, 2011
Arresto Biosciences, Inc. [Member]
Deferred Tax Liabilities [Member]
|
Dec. 31, 2011
Calistoga Pharmaceuticals, Inc. [Member]
|
Apr. 02, 2011
Calistoga Pharmaceuticals, Inc. [Member]
|
Jul. 08, 2010
CGI Pharmaceuticals, Inc. [Member]
|
Jul. 08, 2010
CGI Pharmaceuticals, Inc. [Member]
Deferred Tax Assets [Member]
|
Jul. 08, 2010
CGI Pharmaceuticals, Inc. [Member]
Deferred Tax Liabilities [Member]
|
|---|---|---|---|---|---|---|---|---|---|
| Business Acquisition [Line Items] | |||||||||
| IPR&D | $ 117,000 | $ 149,200 | $ 26,630 | ||||||
| Goodwill | 134,482 | 134,482 | 336,951 | 336,951 | 70,111 | ||||
| Deferred tax assets (liabilities) | 17,417 | (41,705) | 12,656 | (6,313) | |||||
| Other net liabilities assumed | (125) | (1,853) | (984) | ||||||
| Total consideration transferred | $ 227,069 | $ 484,298 | $ 102,100 |